1. Academic Validation
  2. Hippo signaling pathway regulates Ebola virus transcription and egress

Hippo signaling pathway regulates Ebola virus transcription and egress

  • Nat Commun. 2024 Aug 13;15(1):6953. doi: 10.1038/s41467-024-51356-z.
Jingjing Liang 1 Marija A Djurkovic 2 Carson G Leavitt 2 Olena Shtanko 3 Ronald N Harty 4
Affiliations

Affiliations

  • 1 Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA, 19104, USA.
  • 2 Host-Pathogen Interactions, Texas Biomedical Research Institute, 8715 W. Military Drive, San Antonio, TX, 78227, USA.
  • 3 Host-Pathogen Interactions, Texas Biomedical Research Institute, 8715 W. Military Drive, San Antonio, TX, 78227, USA. oshtanko@txbiomed.org.
  • 4 Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA, 19104, USA. rharty@vet.upenn.edu.
Abstract

Filovirus-host interactions play important roles in all stages of the virus lifecycle. Here, we identify LATS1/2 kinases and YAP, key components of the Hippo pathway, as critical regulators of EBOV transcription and egress. Specifically, we find that when YAP is phosphorylated by LATS1/2, it localizes to the cytoplasm (Hippo "ON") where it sequesters VP40 to prevent egress. In contrast, when the Hippo pathway is "OFF", unphosphorylated YAP translocates to the nucleus where it transcriptionally activates host genes and promotes viral egress. Our data reveal that LATS2 indirectly modulates filoviral VP40-mediated egress through phosphorylation of AMOTp130, a positive regulator of viral egress, but more surprisingly that LATS1/2 kinases directly modulate EBOV transcription by phosphorylating VP30, an essential regulator of viral transcription. In sum, our findings highlight the potential to exploit the Hippo pathway/Filovirus axis for the development of host-oriented countermeasures targeting EBOV and related filoviruses.

Figures
Products